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Edited by Ulrike KutayAbstract Bromodomains present in Brd4 and other chromatin
proteins interact with acetylated histones to regulate transcrip-
tion and cell growth. To study Brd4–chromatin interactions
in vivo, histone H4 tail peptides were fused to a synthetic protein
transduction domain (PTD) derived from the human immunode-
ﬁciency virus Tat and delivered into cultured cells. Acetyl-H4
peptides, but not unacetylated H4 peptides inhibited real time
Brd4–chromatin interactions in living cells as assessed by ﬂuo-
rescence recovery after photobleaching assays. The acetyl-H4
peptides also inhibited an interaction of Brd4 with chromosomes
during mitosis and reduced cell growth potential. Together,
PTD-based delivery of histone tail peptides oﬀers a novel means
to study the mechanism and biological signiﬁcance of bromodo-
main–chromatin interactions in vivo.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Acetylation of various lysine (K) residues in the histone tails
generates diverse information relevant to gene regulation [1].
The conserved bromodomains present in many chromatin
binding proteins recognize acetyl-Ks on histone tails and each
bromodomain is thought to distinguish residue speciﬁc acety-
lation [2]. Brd4, a ubiquitous nuclear protein, carries two
bromodomains through which it interacts with acetylated his-
tones and regulates transcription and cell growth [3,4]. We pre-
viously showed that the interaction of Brd4 with acetylated
chromatin persists even during mitosis [3,5]. While bromodo-
main–acetyl histone interactions have been extensively studied
in vitro [2], studies of this interaction in living cells have been
diﬃcult to undertake, due to the lack of appropriate in vivo
methods.Abbreviations: FRAP, ﬂuorescence recovery after photobleaching;
GFP, green ﬂuorescent protein; PTD, peptide transduction domain
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doi:10.1016/j.febslet.2008.03.044The peptide transduction domains (PTDs) represent small,
positively charged peptides that can penetrate through the cell
membrane. When fused, PTDs are capable of delivering cargo
proteins of many sizes into cultured cells and animals [6,7]. A
HIV Tat peptide and its derivatives, extensively studied among
various PTDs, are shown to be rapidly and eﬃciently incorpo-
rated into cultured cells even when fused to large cargo pro-
teins [8]. Using a synthetic PTD, we introduced unacetylated
and acetylated histone H4 tail peptides into cultured cells.
Our results indicate that PTD-delivered acetyl H4 peptides,
but not unacetylated peptides interact with endogenous Brd4
in vivo, resulting in an inhibition of Brd4–chromatin interac-
tions during interphase and mitosis, profoundly aﬀecting cell
growth properties.2. Materials and methods
2.1. PTD-histone tail peptides uptake
PTD peptides were synthesized by Alpha Diagnostic International
(Fig. 1A). P19 embryonal carcinoma cells and NIH3T3 ﬁbroblasts
were incubated with 100–500 nM of peptides diluted in complete media
for 4–6 h at 37 C. For ﬂow cytometry, cells were incubated with
FITC-conjugated PTD-peptides, trypsinized, and washed before
analysis.
2.2. Fluorescence recovery after photobleaching (FRAP)
FRAP assays were performed with NIH3T3 cells transduced with
retroviral vectors for Brd4 small hairpin (sh) RNA and for a green
ﬂuorescent protein (GFP) fused Brd4 resistant to shRNA [9]. FRAP
assays were performed essentially as described [3,10]. Photobleaching
was carried out on a small circular area (0.5-lm radius, 25 pixels) in
the nucleus at the maximum laser power. Thirty prebleach images
were acquired before a bleach pulse of 24 ms. Fluorescence recovery
was monitored at low laser intensity (0.1% of a 45-mW laser) at
49 ms intervals for 14.68 s. Data points were binned so that later time
points were evenly distributed on a logarithmic time scale [11]. Hier-
archical clustering was used to identify FRAP curves with similar
behavior. The distance between any pair of FRAP curves was deﬁned
as the sum of the squared residuals computed at each of the logarith-
mically distributed time points. Cluster trees were generated using the
Matlab routine ‘‘linkage’’ with the ‘‘group average’’ method. FRAP
curves within the same cluster were averaged and then ﬁt with the
function
frapðtÞ ¼ hþ ð1 hÞe 1qt I0 1qt
 
þ I1 1qt
  
;
where I0 and I1 are Bessel functions of the ﬁrst kind, h is the bleach
depth and q is the recovery rate. h and q are free parameters deter-
mined by ﬁtting the averaged FRAP data with the Matlab routine
nlinﬁt.European Biochemical Societies.
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Fig. 1. Delivery of PTD-acetyl histone tail peptides into cultured cells. (A) Schematic diagram of PTD-peptides tested in this work. All peptides were
acetylated at the N-terminus and aminated (NH2) at the C-terminus for stability. The position of acetylated lysine is marked by Ac. (B) Flow
cytometry analysis of PTD-peptide uptake. P19 and NIH3T3 cells were incubated with FITC-PTD-4 fused to unacetylated H4 for 4 h, trypsinized,
and FITC signals were detected in ﬂow cytometry. (C) Kinetics of PTD-peptide uptake. Cells were incubated with the above peptides for the
indicated times and uptake was monitored as above. (D) NIH3T3 cells were incubated with FITC-PTD-4 fused to unacetylated H4 for 4 h and the
intracellular distribution of FITC signals was viewed by confocal microscopy. (E) Cells were incubated with PTD-4 fused to unacetylated or tetra-
acetylated H4 tail peptides for 4 h and uptake was monitored as above.
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sum-of-squares F-test [12]. Averaged FRAP curves from two clusters
were ﬁt either with the same q (null-hypothesis model) or two indepen-
dent qs (alternative model). The squared sum of residuals and the de-
grees of freedom for each model were combined to calculate an F
value. P values were then computed from the F distribution. The best
ﬁts for the alternative model were found using the Matlab routine nlin-
ﬁt, while the best global ﬁt for the null-hypothesis model was found
using the Matlab routine fminsearch which minimized the sum of
squared residuals for the concurrent ﬁt.
2.3. Immunostaining of mitotic cells and colony forming assay
P19 cells were treated with nocodazole (100 ng/ml) for 6 h. Mitotic
cells collected by mitotic shake-oﬀ were incubated in the presence of
PTD-peptides for 45 min at 37 C. Cells were stained with Brd4 as in [5].3. Results and discussion
3.1. Intracellular delivery of PTD-histone tail peptides
With the aim of modulating Brd4–chromatin interactions
in living cells, histone H4 tail peptides listed in Fig. 1A werefused to PTD-4, a synthetic peptide derived from HIV Tat,
shown to be more eﬃcient in cellular uptake than the origi-
nal peptide [8]. To increase nuclear delivery, a nuclear trans-
location signal (NLS) from the simian virus 40 large T
antigen was placed in between. NIH3T3 and P19 cells were
incubated with FITC-labeled versions of peptides for 4 h,
trypsinized to remove unincorporated peptides, and ﬂuores-
cence uptake was measured by ﬂow cytometry. Results
showed dose-dependent single peak uptake patterns
(Fig. 1B). Time course analysis in Fig. 1C showed that pep-
tides were taken up rapidly in the initial 1 h, but reached
steady state at a lower level by 4 h, indicating that equilib-
rium between incorporation and processing was attained
by this time. Upon microscopic inspection, FITC signals
were found both in the cytoplasm and the nucleus
(Fig. 1D), as reported for other peptides [7]. In Fig. 1E, up-
take of PTD-acetyl H4 peptides (acetylated at K4, K8, K12,
and K16) was lower than that of unacetylated peptides. This
is likely to be due to an alteration of overall charges in the
peptides caused by acetylation [6].
Pre-bleach
Post-bleach, 0 s
0.25 s
2.5 s
Fig. 3. FRAP procedure. Live-cell images of a cell before and after
photobleaching. A circular spot (red circle) was photobleached for
24 ms in the nucleus of NIH3T3 cells expressing GFP-Brd4 (Fig. 2)
and incubated with PTD-acetyl H4. The ﬁrst image after the
photbleach is shown (0 s). At subsequent time points, ﬂuorescence
recovers within the photobleached spot (example images at 0.25 s and
2.5 s are shown). FRAP recovery curves were generated by computing
the average ﬂuorescent intensity within the region deﬁned by the red
circle at all time points, and then subtracting background (as measured
from the average intensity inside the blue circle) and normalizing by
the loss of ﬂuorescence due to repeated imaging (green circle).
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mobility
FRAP analysis is an excellent way to assess real time inter-
actions between histones and chromatin binding proteins
in vivo [10,13]. To test the eﬀect of PTD-H4 peptides on
Brd4 FRAP mobility, we ﬁrst constructed NIH3T3 cells
expressing exogenous GFP-Brd4 in which endogenous Brd4
expression was reduced by Brd4 shRNA. Fig. 2A and B shows
that double-transduced cells expressed GFP-Brd4 with mark-
edly reduced endogenous Brd4. The levels of GFP-Brd4 in
these cells were comparable to those of endogenous Brd4 in
control cells. GFP-Brd4 and endogenous Brd4 displayed com-
parable salt extraction proﬁles (Fig. 2C). Also, these cells
showed similar patterns of histone H3 and H4 acetylation
and grew at a comparable rate (Fig. 2D and E). These tests val-
idated the use of these cells in FRAP analysis. Importantly, the
use of these cells allowed us to avoid testing overexpressed
Brd4 in our FRAP assays. For photobleaching, we selected cir-
cular spots in the nuclei of GFP-Brd4 cells in regions showing
a diﬀuse, homogeneous ﬂuorescence distribution (Fig. 3, red
circle), and avoided nucleoli (dark regions) or regions contain-
ing bright puncta. Typical images from a ﬂuorescence recovery
are shown at 0.25 s and 2.5 s (Fig. 3). Using such images, we
measured average ﬂuorescent intensities within the bleach spot
as a function of time to generate individual FRAP curves for
each cell. Typically for a given treatment 15 such curves were
averaged to produce the representative curves shown in
Fig. 4A and B for cells incubated with diﬀerent PTD-acetylA
D E
B C
Fig. 2. Dosage adjusted expression of GFP-Brd4 used for FRAP analysis. (A
Brd4 shRNA (right lane, GFP-Brd4 + Brd4 shRNA). For control, cells were t
by immunoblot. (B) The distribution of GFP-Brd4 in the transduced cells dur
Brd4/Brd4 shRNA transduced cells prepared with buﬀer of increasing NaCl
Brd4 antibody. (D) Histones from the above cells were tested for acetylation
transduced NIH3T3 cells were cultured for the indicated days and total cellH4 peptides. Averaging of many individual FRAP curves from
a particular treatment resulted in very small standard error
bars on every point on the curves, enabling us to distinguish
closely spaced curves. For example, even allowing for experi-
mental error, the tetra-acetylated H4 peptide produced a
Brd4 FRAP curve which was distinctly faster than the control,
with every point in the tetra-acetylated H4 peptide curve) NIH3T3 cells were transduced with pMSCV-EGFP-Brd4 and pSuper-
ransduced with empty vectors (left lane, Mock). Cell lysates were tested
ing interphase or mitosis is shown. (C) Extracts from mock and EGFP-
concentrations (mM). Brd4 was detected by immunoblot with an anti-
by immunoblot. (E) Mock transduced and EGFP-Brd4/Brd4 shRNA
yields were plotted on the Y-axis.
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Fig. 4. Altered mobility of GFP-Brd4 following PTD-acetyl peptide delivery. (A) Cells were incubated with the indicated PTD-H4 peptides for 1 h
prior to photobleaching. The curves represent the average recovery of 15 cells for each treatment. (B) Cells were incubated with the indicated PTD-
peptides (500 nM) and ﬂuorescence recovery was monitored as in (A). (C) Control and tetra-acetylated H4 curves from (A) shown with standard
error bars on each time point. Note that the diﬀerences between the curves are much larger than the standard errors. (D) H4 and mono-acetlyated
H4AcK12 curves from (B) shown with standard error bars. The diﬀerences between the curves at intermediate time points are much larger than the
standard errors. (E, F) Hierarchical cluster trees for the FRAP curves in (A) and (B). Branch lengths on the tree reﬂect the distance between pairs of
averaged FRAP curves deﬁned by the sum of squared residuals between each pair of curves. (G, H) Averaged FRAP curves were computed for the
clusters in (C) and (D). The curves were ﬁt with a mathematical model (see Section 2) to obtain an estimate of the recovery rate q. An F test was
performed to determine whether the averaged curves could be described by the same q value (null hypothesis) or two distinct q values (alternative
hypothesis).
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for most of the intermediate time points for the mono-acety-
lated H4 curve (H4AcK12, Fig. 4D). These and all of the other
diﬀerences reported here were also highly reproducible from
one day to the next. All diﬀerences reported here were consis-
tently seen in at least three separate experiments. It is known
that small diﬀerences in FRAP curves can reﬂect large diﬀer-
ences in binding interactions [10], since FRAP curves reﬂect
both binding and diﬀusion, and the latter process is not signif-
icantly altered by most biological perturbations.
The results showed that the tetra-acetyl H4 peptides consis-
tently increased Brd4 mobility, while the unacetylated peptides
had no eﬀect, as the mobility was indistinguishable from that
of control cells treated with medium alone. Among mono-acet-
ylated H4 peptides, those with AcK5 and AcK12, but not with
AcK8 and K16, yielded consistently faster recovery compared
with unacetylated peptides, with the diﬀerence somewhat smal-
ler than that seen with tetra-acetylated peptides (Fig. 4B and D
vs. A and C). These results indicated that Brd4 speciﬁcally
interacted with H4 peptides containing AcK5 and AcK12. Sig-
niﬁcantly, this speciﬁcity agrees with that observed with
in vitro Brd4–peptide interactions [3].
A quantitative analysis of the data in Fig. 4A using a cluster-
ing algorithm showed that control samples (medium alone)
and those with the unacetylated H4 peptides formed a single
cluster, while those with tetra-acetylated H4 peptides formed
a separate cluster (Fig. 4E). In addition, peptides with mono-
acetylation at K5 and K12 displayed a distinct cluster from
those acetylated at K8 and K16 (Fig. 4F). These results sup-
port the notion that the above diﬀerences in FRAP recoveries
are signiﬁcant. To further assess the signiﬁcance of the data,A
B C
Fig. 5. PTD-acetyl histone peptides impair Brd4–chromosome interactions.
were allowed to proceed in the presence of PTD-peptides for 45 min. (B) Ce
Brd4 antibody and Hoechst 33342. Typical Brd4 distributions on mitotic ch
shown. (C) Quantiﬁcation of Brd4–chromosome interactions. P19 cells treate
concentrations. The number of cells in which Brd4 was (or was not) associa
percentage of mitotic cells with Brd4 on chromosomes. Open bars indicate the
250 cells were counted for each sample. Similar results were observed in thrthe FRAP curves were averaged and ﬁt with a mathematical
formula for FRAP recoveries that contained a free parameter
q that deﬁnes the rate of the FRAP recovery. An F test was
used to determine the statistical signiﬁcance of the groupings
in Fig. 4E and F. Highly signiﬁcant P values were obtained
in all cases indicating that the changes observed in the FRAP
recoveries are statistically signiﬁcant (Fig. 4G and H). These
analyses demonstrated that PTD-tetra-acetyl H4 peptide in-
creased Brd4 mobility most, while AcK5 and AcK12 caused
a less pronounced increase in Brd4 mobility. On the other
hand, AcK8, AcK16, and unacetylated peptides did not have
an eﬀect. The analyses supported the idea that PTD-H4 pep-
tides, through speciﬁc acetyl residues, bound to Brd4 in living
cells, leading to partial inhibition of Brd4–chromatin interac-
tions in vivo.
3.3. PTD-acetyl H4 peptides inhibit association of Brd4 with
mitotic chromosomes and reduce colony formation
Brd4 remains bound on chromosomes even during mitosis,
since the interaction with acetyl histones persists throughout
cell cycle [3,5]. Brd4–mitotic chromosome interactions are
transiently disrupted by anti-mitotic drugs such as nocodazole,
temporally releasing Brd4 from chromosomes, although the
drug withdrawal rapidly restores Brd4–chromosome interac-
tions [5]. Restoration of Brd4–chromosome interactions tested
after drug removal provides a sensitive way to assess the eﬀect
of PTD-acetyl H4 peptides on mitotic Brd4–histone interac-
tions. P19 cells pre-treated with nocodazole were then incu-
bated with PTD-H4 peptides and Brd4–chromosome
interactions were monitored by microscopic inspection
(Fig. 5A). In the presence of unacetylated peptides, Brd4(A) P19 cells were treated with nocodazole, washed and mitotic cells
lls incubated with or without peptides were immunostained with anti-
romosome (left panels) and outside of chromosome (right panels) are
d with nocodazole were incubated with PTD-peptides at the indicated
ted with mitotic chromosomes were counted. Solid bars represent the
percentage of cells with Brd4 outside of mitotic chromosomes. At least
ee independent experiments.
AB C
Fig. 6. The eﬀect of acetyl-peptides on the colony forming ability. (A) Diagram of colony forming assays. (B) Cells treated with or without
nocodazole were incubated with PTD with unacetylated or tetra-acetylated H4 peptides (500 nM). The number of colonies produced after PTD-
peptide delivery was compared to that produced by untreated cells and is expressed as the percentage of colonies relative to control. (C) Cells treated
with nocodazole (500 ng/ml) were incubated with the indicated PTD-peptides and colony forming assays were performed as above.
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most cells (Fig. 5B). In contrast, in the presence of acetyl pep-
tides, Brd4 remained outside of chromosomes in a large frac-
tion of cells. Quantiﬁcation in Fig. 5C conﬁrmed these
results, indicating that acetyl-H4 peptides inhibited Brd4–mi-
totic chromosome interactions. It should be noted here that
due to the nuclear membrane breakdown, PTD-H4 peptides
may be more eﬃciently delivered during mitosis than during
interphase, likely allowing PTD peptides to gain direct access
to chromatin. Nocodazole treatment has been shown to reduce
the proliferative potential of cells [5,14]. We tested whether
PTD-H4 peptides aﬀect colony formation after nocodazole
treatment (Fig. 6A). Cells incubated with unacetylated H4 pep-
tides produced comparable numbers of colonies as cells treated
with nocodazole alone (Fig. 6B). In contrast, signiﬁcantly few-
er colonies were generated when cells were incubated with tet-
ra-acetyl H4 peptides, indicating that acetyl-H4 peptides
further reduced cells growth potential. In Fig. 6C, K5
mono-acetylated H4 also reduced colony formation, although
other mono-acetylated peptides did not have an eﬀect. Thus,
inhibition of colony formation generally correlated with the
ability of peptides to inhibit Brd4–chromatin interactions
tested in FRAP assays.
The use of the PTD approach provided a new means to ad-
dress the role of histone acetylation in vivo. While various pro-
teins have been delivered into the cells by this method [6,7,15],
to our knowledge, delivery of chromatin constituents has not
been reported to date. It seems clear that under the conditions
employed here, PTD-acetyl H4 peptides bound to Brd4 with
suﬃcient aﬃnity to alter Brd4 real time mobility, leading to
the inhibition of global Brd4–chromatin interactions in vivo.
This study also revealed that Brd4 bound to H4 peptides with
exquisite acetyl residue speciﬁcity in vivo, the type of informa-
tion diﬃcult to obtain by standard biochemistry. An addi-tional piece of interesting information generated in this work
is that Brd4 binds free acetyl H4 tails without a globular
nucleosomal base. The use of PTD-based acetyl H4 delivery al-
lowed us to verify the biological signiﬁcance of Brd4–acetyl
chromatin interactions, as evidenced by the inhibition of cell
growth. Given that histone tails are modiﬁed by numerous
ways, creating diverse information on transcription and con-
vey epigenetic memory, PTD-histone peptides may provide a
versatile new avenue to study the role of histone modiﬁcations
in gene expression and epigenetic regulation.
Acknowledgements: We thank A. Dey, T. Tamura, and T. Kanno for
helpful discussions and critical reading of the manuscript. This work
was supported by the Intramural Programs of NICHD and NCI, NIH.References
[1] Fischle, W., Wang, Y. and Allis, C.D. (2003) Histone and
chromatin cross-talk. Curr. Opin. Cell Biol. 15, 172–183.
[2] Zeng, L. and Zhou, M.M. (2002) Bromodomain: an acetyl-lysine
binding domain. FEBS Lett. 513, 124–128.
[3] Dey, A., Chitsaz, F., Abbasi, A., Misteli, T. and Ozato, K. (2003)
The double bromodomain protein Brd4 binds to acetylated
chromatin during interphase and mitosis. Proc. Natl. Acad. Sci.
USA 100, 8758–8763.
[4] Wu, S.Y. and Chiang, C.M. (2007) The double bromodomain-
containing chromatin adaptor Brd4 and transcriptional regula-
tion. J. Biol. Chem. 282, 13141–13145.
[5] Nishiyama, A., Dey, A., Miyazaki, J. and Ozato, K. (2006) Brd4
is required for recovery from antimicrotubule drug-induced
mitotic arrest: preservation of acetylated chromatin. Mol. Biol.
Cell 17, 814–823.
[6] Wender, P.A., Mitchell, D.J., Pattabiraman, K., Pelkey, E.T.,
Steinman, L. and Rothbard, J.B. (2000) The design, synthesis, and
evaluation of molecules that enable or enhance cellular uptake:
peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97,
13003–13008.
A. Nishiyama et al. / FEBS Letters 582 (2008) 1501–1507 1507[7] Wadia, J.S. and Dowdy, S.F. (2002) Protein transduction
technology. Curr. Opin. Biotechnol. 13, 52–56.
[8] Ho, A., Schwarze, S.R., Mermelstein, S.J., Waksman, G. and
Dowdy, S.F. (2001) Synthetic protein transduction domains:
enhanced transduction potential in vitro and in vivo. Cancer Res.
61, 474–477.
[9] Mochizuki, K. et al. (2008) The bromodomain protein Brd4
stimulates G1 gene transcription and promotes progression to S
phase. J. Biol. Chem. 283, 9040–9048.
[10] Stavreva, D.A., Muller, W.G., Hager, G.L., Smith, C.L. and
McNally, J.G. (2004) Rapid glucocorticoid receptor exchange at a
promoter is coupled to transcription and regulated by chaperones
and proteasomes. Mol. Cell Biol. 24, 2682–2697.
[11] Waharte, F., Brown, C.M., Coscoy, S., Coudrier, E. and
Amblard, F. (2005) A two-photon FRAP analysis of thecytoskeleton dynamics in the microvilli of intestinal cells.
Biophys. J. 88, 1467–1478.
[12] Motulsky, H.J. and Christopoulus, A. (2003). Fitting models to
biological data using linear and nonlinear regressionA practical
guide to curve ﬁtting, GraphPad Software Inc., San Diego, CA.,
pp. 160–162.
[13] Phair, R.D. et al. (2004) Global nature of dynamic protein–
chromatin interactions in vivo: three-dimensional genome scan-
ning and dynamic interaction networks of chromatin proteins.
Mol. Cell Biol. 24, 6393–6402.
[14] Bhalla, K.N. (2003) Microtubule-targeted anticancer agents and
apoptosis. Oncogene 22, 9075–9086.
[15] Morris, M.C., Depollier, J., Mery, J., Heitz, F. and Divita, G.
(2001) A peptide carrier for the delivery of biologically active
proteins into mammalian cells. Nat. Biotechnol. 19, 1173–1176.
